Performance peptides are compounds that signal your body to release more of its own growth hormone. In a two-year trial in older adults, this approach increased lean body mass, although strength and physical function did not change.1 Unlike growth hormone injections, these peptides – which are themselves synthetic – work through your body’s own regulatory system, so growth hormone is released in pulses that stay under normal feedback control.
Common protocols use growth hormone secretagogues such as Sermorelin, CJC-1295, and Ipamorelin with the goal of improving body composition, energy levels, and recovery. Long-term safety data are still limited, and blood sugar can rise.2
How It Works
As we age, growth hormone naturally declines — along with recovery, performance, and body composition.31
Peak Performance Peptides use growth hormone secretagogues — compounds that signal your body to naturally produce and release growth hormone.
No growth hormone injections
No forced replacement
No shortcuts
Just your biology — optimized.
Choose Your Performance Path
Option 1: Sermorelin Protocol
Foundational optimization for recovery, sleep, and longevity
$175/month
Sermorelin is a synthetic analog of growth hormone-releasing hormone, studied mainly in children with growth hormone deficiency and in small trials in older adults. Taken at bedtime, it signals your pituitary gland to release its own growth hormone, raising nighttime growth hormone levels.45
Amplified results for body composition, recovery, and performance
$175/month
This dual-peptide protocol is designed for those ready for more advanced performance optimization.
CJC-1295 extends growth hormone release for sustained elevation67
Ipamorelin triggers a short pulse of growth hormone and, in animal studies, did not raise cortisol89
In human studies, combining a GHRH-type peptide with a GHRP-type peptide released more growth hormone than either alone – a synergistic effect, although this specific pairing has not yet been tested in clinical trials.10
The most clinically validated protocol in this pathway
Low Dose Protocol: $250/month
High Dose Protocol: $350/month
Both are given five out of seven nights. Every patient starts at the low dose and moves up only if needed.
Tesamorelin is a growth-hormone-releasing hormone analog and the only peptide carrying an FDA approval for reducing visceral abdominal fat — the fat around the organs that carries genuine metabolic risk rather than a cosmetic one.1112 That approval was granted for adults with HIV-associated lipodystrophy; YoungerMeMD prescribes it off-label, under supervision, for adult metabolic optimization.
Best for:
Persistent midsection fat that has not responded to diet or exercise
Metabolic markers — triglycerides, blood sugar, inflammation — trending the wrong way
Early changes in memory, focus, or mental sharpness
Patients over 35 ready for the most advanced protocol in the program
Tesamorelin carries specific clinical cautions and is prescribed only after a full evaluation — the details are on its own page.
Your starting point is a comprehensive, 1-hour deep dive:
Full lab testing & bloodwork
Medical + lifestyle evaluation
Personalized performance plan
👉 We identify what’s limiting your performance — and how to fix it.
STEP 2
Unlock Membership
$279/month
Your membership includes:
Direct access to your clinical team
3–4 visits per year
Unlimited messaging support
Supplement discounts
Ongoing plan optimization
✔ No hidden fees ✔ Continuous guidance ✔ Fully personalized care
STEP 3
Add Your Performance Specialty Treatment Plan
$175/month
Layer Peak Performance Peptides into your plan alongside options like:
Hormone Replacement Therapy (HRT)
Weight Loss Programs
Cardiometabolic optimization
What are performance peptides used for?
Performance peptides are used with the goal of improving body composition, recovery, and energy by increasing the body’s own growth hormone release. The clearest evidence is for increased lean mass; benefits for strength have not been consistently shown.113
How quickly do performance peptides work?
Many individuals begin noticing improvements in sleep, recovery, and energy within a few weeks, while changes in body composition and performance typically develop over a longer period with consistent use.
Are performance peptides the same as steroids?
No. Anabolic steroids are testosterone-like hormones. Performance peptides are synthetic peptides that prompt your pituitary to release its own growth hormone, in pulses that stay under normal feedback control.2
Who is a good candidate for peptide therapy?
Peptide therapy is often used by individuals looking to improve recovery, build lean muscle, optimize performance, or address age-related declines in energy and strength.
What’s the difference between Sermorelin and CJC-1295 + Ipamorelin?
Sermorelin is typically used as a foundational approach for gradual optimization, while CJC-1295 + Ipamorelin combines two different growth hormone signals. The two options have not yet been compared head-to-head in clinical trials.
Do I need to stay on peptides long-term?
Treatment plans are individualized. Some people use peptides in cycles for targeted goals, while others incorporate them into a longer-term performance or longevity strategy under medical guidance.
How do these peptides differ from hormone replacement?
Rather than supplying growth hormone directly, growth hormone secretagogues signal your body to release its own growth hormone, in pulses that remain subject to normal feedback.2
What changes might appear first?
Improved sleep quality is often the first noticeable change, with energy, recovery, and body composition improvements building over time.
Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991. PMID 1939523 · doi:10.1210/jcem-73-5-1081↩
Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs 1999. PMID 18031173 · doi:10.2165/00063030-199912020-00007↩
Khorram O, Laughlin GA, Yen SS. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. J Clin Endocrinol Metab 1997. PMID 9141536 · doi:10.1210/jcem.82.5.3943↩
Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab 2006. PMID 16352683 · doi:10.1210/jc.2005-1536↩
Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab 2006. PMID 17018654 · doi:10.1210/jc.2006-1702↩
Gobburu JV, Agersø H, Jusko WJ, et al. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res 1999. PMID 10496658 · doi:10.1023/a:1018955126402↩
Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 1998. PMID 9849822 · doi:10.1530/eje.0.1390552↩
Bowers CY, Reynolds GA, Durham D, et al. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 1990. PMID 2108187 · doi:10.1210/jcem-70-4-975↩
U.S. Food and Drug Administration. EGRIFTA SV (tesamorelin for injection) prescribing information, BLA022505 (openFDA drug label, effective 20260729). openFDA Drug Label API 2026. Source↩
Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol 2019. PMID 31301983 · doi:10.1016/S2213-8587(19)30084-1↩
Estimates nutrient-related markers from DNA methylation with an at-home finger-prick kit. Not a diagnostic test; flagged results are confirmed with standard blood work.